SEARCH

SEARCH BY CITATION

References

  • 1
    Lok AS. Chronic hepatitis B. N Engl J Med 2002; 346: 1682-1683.
  • 2
    Beasley RP, Lin C-C, Hwang L-Y, Chien C-S. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981; 2: 1129-1133.
  • 3
    de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993; 118: 191-194.
  • 4
    Manno M, Camma C, Schepis F, Bassi F, Gelmini R, Giannini F, et al. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004; 127: 756-763.
  • 5
    Fattovich G, Olivari N, Pasino M, D'Onofrio M, Martone E, Donato F. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. Gut 2008; 57: 84-90.
  • 6
    McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Int Med 1990; 150: 1051-1054.
  • 7
    Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chonic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American population. HEPATOLOGY 1995; 22: 432-438.
  • 8
    Villenueve J, Desrochera M, Infante- Rivard C, Willems B, Raymond G, Bourcier M, et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994; 106: 1000-1005.
  • 9
    Tong M, Blatt L, Tyson K, Kao V. Death from liver disease and development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection: a prospective study. Gastroenterol Hepatol 2006; 2: 41-47.
  • 10
    Selby J, Smith D, Johnson E, Raebel M, Friedman G, McFarland B. Kaiser Permanente Medical Care Program. In: Strom B, ed. Pharmacoepidemiology. West Sussex, UK: John Wiley & Sons Ltd; 2005: 241-259.
  • 11
    Hutfless SM, Weng X, Liu L, Allison J, Herrington L. Mortality by medication use among patients with inflammatory bowel disease 1996-2003. Gastroenterology 2007; 133: 1779-1786.
  • 12
    Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. HEPATOLOGY 2007; 46: 912-921.
  • 13
    McKillop IH, Schrum LW. Role of alcohol in liver carcinogenesis. Semin Liver Dis 2009; 29: 222-232.
  • 14
    Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, Peto R. Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer 2003; 107: 106-112.
  • 15
    Bravi F, Bosetti C, Tavani A, L Vecchia C. Coffee drinking and hepatocellular carcinoma: an update. HEPATOLOGY 2009; 50: 1317-1318.
  • 16
    Chen G, Lin WL, Shen FS, Iloeje UH, London W, Evans A. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 2006; 101: 1797-1803.
    Direct Link:
  • 17
    Chan HL, Tse CH, Mo F, Koh J, Wong VW, Wong GL, et al. High viral load and hepatitis B virus subgenotype C are associated with increased risk of hepatocellular carcinoma. J Clin Oncol 2008; 26: 177-182.
  • 18
    Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 2010; 30: 3-16.
  • 19
    Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. HEPATOLOGY 2009; 50: 1-36.
  • 20
    Lok A, McMahon BJ. Chronic hepatitis B. HEPATOLOGY 2001; 34: 1225-1240.
  • 21
    Grinsdale J, Woodfill C. Acute hepatitis B in California, 1990-2002: progress towards the elimination of hepatitis B virus transmission [abstract]. In: The 37th National Immunization Conference; 2003 March 17-20; Chicago, IL; 2003.
  • 22
    Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR 2006; 55: 1-41.
  • 23
    Centers for Disease Control and Prevention. Surveillance for acute viral hepatitis—United States, 2006. Surveillance summaries. MMWR 2008; 57: 1-24.
  • 24
    Pungpapong S, Kim WR, Poterucha J. Natural history of hepatitis B virus Infection: an update for clinicians. Mayo Clin Proc 2007; 82: 967-975.
  • 25
    El-Serag HB, Lok AS, Thomas DL. The dawn of a new era: transforming our domestic response to hepatitis B & C. Gastroenterology 2010; 138: 1225-1230.
  • 26
    Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP. Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment. HEPATOLOGY 2008; 47: 1150-1157.
  • 27
    Harris H, Ramsay M, Andrews N; HCV National Register Steering Group. Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure. Epidemiol Infect 2006; 134: 472-477.